IDYA icon

IDEAYA Biosciences
IDYA

Overview Fund Activity

117 hedge funds and large institutions have $822M invested in IDEAYA Biosciences in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+5
Holders Change %
+4.46%
% of All Funds
1.89%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
54
Reduced
28
Closed
12
Calls
$6.79M
Puts
$7K
Net Calls
+$6.78M
Net Calls Change
-$329K

Top Buyers

1
BlackRock
1
BlackRock
New York
$64.3M
2
State Street
2
State Street
Massachusetts
$42.2M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$41.6M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$40M
5
Ameriprise
5
Ameriprise
Minnesota
$7.46M

Top Sellers

1
BI
1
BVF Inc
California
$40.1M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$12.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$16.1M
4
LGM
4
Logos Global Management
California
$70.9M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$10.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
Axa
26
Axa
France
$6.2M -$1.6M -88,149 -21%
CS
27
Candriam SCA
Luxembourg
$5.09M +$454K +25,000 +10%
NCM
28
Nantahala Capital Management
Connecticut
$4.61M – – –
Millennium Management
29
Millennium Management
New York
$3.39M +$3.39M +186,427 New
Bank of America
30
Bank of America
North Carolina
$3.09M +$1.05M +57,998 +52%
First Manhattan
31
First Manhattan
New York
$3M – – –
Goldman Sachs
32
Goldman Sachs
New York
$2.92M +$892K +49,110 +44%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$2.8M +$766K +42,144 +38%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.77M +$574K +31,604 +26%
Two Sigma Investments
35
Two Sigma Investments
New York
$2.54M +$2.33M +128,063 +1,076%
OM
36
Opaleye Management
Massachusetts
$2.52M +$2.49M +137,300 +9,153%
Norges Bank
37
Norges Bank
Norway
$2.5M +$2.5M +137,500 New
TCM
38
Tekla Capital Management
Massachusetts
$2.42M – – –
Two Sigma Advisers
39
Two Sigma Advisers
New York
$2.28M +$1.59M +87,700 +231%
Charles Schwab
40
Charles Schwab
California
$2.15M +$480K +26,434 +29%
UBS Group
41
UBS Group
Switzerland
$2.08M +$1.81M +99,753 +672%
Invesco
42
Invesco
Georgia
$1.98M +$1.76M +96,690 +776%
IBT
43
International Biotechnology Trust
United Kingdom
$1.98M – – –
Barclays
44
Barclays
United Kingdom
$1.72M +$431K +23,735 +34%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.69M +$38.2K +2,100 +2%
Ensign Peak Advisors
46
Ensign Peak Advisors
Utah
$1.68M -$141K -7,760 -8%
GCM
47
Ghisallo Capital Management
Massachusetts
$1.59M -$1.59M -87,500 -50%
Citigroup
48
Citigroup
New York
$1.27M -$643K -35,373 -34%
SCM
49
Sio Capital Management
New York
$1.27M – – –
CSS
50
Cubist Systematic Strategies
Connecticut
$1.21M +$833K +45,824 +219%
1
2
3 4 5